ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,084.61
-0.26%
Dow Jones
42,840.26
1.18%
Gold vs US Dollar
2,623.175
0.00%
Brent Oil
72.72
0.00%
Bitcoin
96,616.81
-0.61%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ASLAN Pharmaceuticals Ltd (ASLN)

  7. ASLAN Pharmaceuticals Ltd (ASLN) News

ASLAN Pharmaceuticals (ASLN)

ASLAN Pharmaceuticals Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ASLN
DateTimeSourceHeadlineSymbolCompany
17/07/202411:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
17/07/202411:25GlobeNewswire Inc.ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary LiquidationNASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/07/202411:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/06/202420:46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/06/202420:32Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ASLNASLAN Pharmaceuticals Ltd
31/05/202420:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
09/05/202411:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/05/202411:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/03/202412:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202421:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/01/202412:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
08/01/202412:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/12/202321:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
08/12/202321:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
27/10/202312:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/10/202312:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
16/10/202310:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/08/202311:33Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/08/202311:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
20/07/202311:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202312:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202312:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202311:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/07/202320:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/04/202311:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202321:27Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202320:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/03/202311:33Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/03/202311:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
20/03/202321:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:ASLN

Your Recent History

TSXV
SASK
Atha Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads